MAXHEALTH Stock View

Max Healthcare Institute Ltd

MAXHEALTH Stock View

(NSE)

Trade

₹ 652.35

7.40 | 1.15

Market Cap ₹( Cr.)
633,970.70

Proj. P/E (x)
48.53

Proj. P/BV (x)
7.01

Proj. ROE (%)
15.55

Proj EV / EBITDA (x)
--

Proj. Revenue ( Cr.)
67,133.27

Last Updated On.
26-Nov-2023

 

Copy Link

Max Healthcare Institute Limited is an India-based healthcare company. The Company operates through the Medical and Healthcare Services segment. The Company also operates a homecare business and pathology business under the brand names Max@Home and Max Lab. Max@Home offers health and wellness services at home. Max Lab provides pathology services outside its hospital network. The Company is specialized in providing treatment for cancer care/oncology, cardiac sciences, endocrinology and diabetes, eye care/ophthalmology, gastroenterology, hepatology and endoscopy, laparoscopic/minimal access surgery, neurosciences, liver transplant and biliary sciences, orthopedics and joint replacement, bariatric surgery/metabolic, robotic surgery, kidney transplant, bone marrow transplant, urology, and vascular surgery. The Company owns, operates and provides medical services to facilities in Delhi, Mumbai, Punjab, Uttar Pradesh and Uttarakhand. It has approximately 17 healthcare facilities.

Disclaimer : All estimates (1 year forward) are based on Consensus View provided by Refinitiv.

Technical Data